Latest from Cannyxnews.com
MediPharm Labs Corp. (TSX: LABS) has exported its first shipment of cannabis oil products, approved by the Australian TGA, to Germany. As a result, patients in Germany are now able to access GMP-certified quality medical cannabis through MediPharm Labs German distribution partners.
Only companies that have received Good Manufacturing Practices (GMP) certification are permitted to export cannabis products into the German market. Only a handful of companies have been successful in their attempts to export cannabis oils into the country. This achievement by MediPharm Labs demonstrates Australia’s pharmaceutical excellence and positions Australia as a global leader in the production of cannabis medicines.
“As this first shipment and first sales to Germany mark MediPharm Labs’ entry into the international pharmaceutical industry within a major European market, we are excited by the opportunities that lie ahead as we employ all of our value-added capabilities,” said Warren Everitt, CEO, MediPharm Labs Australia.